Pharmacokinetics of Levosimendan in Pediatric Intensive Care Units

NCT03681379 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2024-08-02

No results posted yet for this study

Summary

To describe pharmacokinetics of levosimendan in neonates and children supported or not with extracorporeal circulation devices (ECMO, CRRT)

Conditions

  • Acute Heart Failure

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
0 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-23
Primary Completion
2019-10-11
Completion
2020-10-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681379 on ClinicalTrials.gov